1 week Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Lags Revenue Estimates Zacks

Caribou Biosciences (CRBU) delivered earnings and revenue surprises of 2.50% and 18.23%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?